We are live on ! Find out more
RA

Royce & Associates Portfolio holdings

AUM $10.1B
1-Year Est. Return 42.88%
This Fund
S&P 500
This Quarter Est. Return
-2.2%
1 Year Est. Return
+42.88%
3 Year Est. Return
+92.52%
5 Year Est. Return
+113.84%
10 Year Est. Return
+608.05%
AUM
$13.4B
AUM Growth
-$1.18B
Cap. Flow
-$624M
Cap. Flow %
-4.67%
Top 10 Hldgs %
7.94%
Holding
1,057
New
56
Increased
305
Reduced
416
Closed
75

Top Buys

Rank Stock Value
1
IOSP icon
Innospec
IOSP
+$25.1M
2
HAE icon
Haemonetics
HAE
+$24.2M
3
CALX icon
Calix
CALX
+$22.2M
4
MXCT icon
MaxCyte
MXCT
+$21.3M
5
FRG
Franchise Group, Inc.
FRG
+$21.3M

Sector Composition

Rank Sector Weight
1 Industrials 24.95%
2 Technology 20.11%
3 Financials 15.36%
4 Consumer Discretionary 13.42%
5 Healthcare 7.39%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
USCR
1051
DELISTED
U S Concrete, Inc.
USCR
-7,682
Closed -$567K
BWL.A
1052
DELISTED
Bowl America Incorporated
BWL.A
-325,000
Closed -$2.86M
HIMS.WS
1053
DELISTED
Hims & Hers Health, Inc. Warrants, each whole warrant exercisable for one Class A Common Stock at an
HIMS.WS
-266,666
Closed -$893K
BPFH
1054
DELISTED
Boston Private Financial Holdings, Inc.
BPFH
-36,235
Closed -$534K
QADA
1055
DELISTED
QAD Inc.
QADA
-62,816
Closed -$5.47M
ORBC
1056
DELISTED
ORBCOMM, Inc.
ORBC
-65,000
Closed -$731K
AZPN
1057
DELISTED
ASPEN TECHNOLOGY INC
AZPN
-24,440
Closed -$3.36M

Similar funds

Royce & Associates's Q3 2021 Portfolio in Review

As of Q3 2021, Royce & Associates held 1,057 positions worth $13.4B, down 8.1% from $14.6B the previous quarter. Its ten largest holdings account for 7.9% of the portfolio.

Royce & Associates withdrew a net $624M in Q3 2021, closing 75 positions and reducing 416 holdings. Its most notable exit was SmileDirectClub, Inc. Class A Common Stock, an estimated $32.3M position sold in full.

By sector, the portfolio is most concentrated in Industrials at 25% of assets, up from 24% a quarter earlier, followed by Technology and Financials.

Against the trend, Royce & Associates opened a new position in Calix worth $23.8M.

  • Royce & Associates's largest Q3 2021 buy was Calix: 480,993 shares worth $23.8M.
  • Royce & Associates added most to Innospec in Q3 2021, an estimated $25.1M increase.
  • Royce & Associates's biggest Q3 2021 reduction was Kulicke & Soffa, cutting an estimated $37.4M.
  • Royce & Associates fully exited SmileDirectClub, Inc. Class A Common Stock in Q3 2021, selling an estimated $32.3M.
  • Royce & Associates's ten largest holdings make up 7.9% of its $13.4B portfolio in Q3 2021.
  • Royce & Associates opened 56 new positions and closed 75 in Q3 2021.
  • Royce & Associates's portfolio value fell 8.1% quarter-over-quarter to $13.4B.

Based on Royce & Associates's 13F filing for Q3 2021, filed 10 Nov 2021.